Page 7 - Nasdaq Cytk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq cytk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cytk Today - Breaking & Trending Today

Cytokinetics Announces Upcoming Presentations at the 2023

Baseline Characteristics from SEQUOIA-HCM to be Presented at HCMS Scientific Sessions on October 6, 2023. ....

United States , San Francisco , Meiling Chen , Michaela Fifer , Ahmed Altibi , Diane Weiser , Martins Maron , Ahmad Masri , Division Of Cardiovascular Medicine , Exchange Commission , University Of California , Hypertrophic Cardiomyopathy Program At Massachusetts , Corporate Communications , Cardiology Research , Cytokinetics Incorporated Nasdaq , Hypertrophic Cardiomyopathy Medical Society , San Francisco Medical Center , Hospital Heart Center , Heart Failure Society Of America , Oregon Health Science University , Hypertrophic Cardiomyopathy Center At Lahey Hospital , Cardiomyopathy Medical Society , Scientific Sessions , Heart Failure Society , Annual Scientific Meeting , Baseline Characteristics ,

Robert I. Blum Sells 12,500 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert I. Blum sold 12,500 shares of Cytokinetics stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $34.90, for a total transaction of $436,250.00. Following the completion of the sale, the chief executive officer now owns 441,417 shares in […] ....

Roberti Blum , Leerink Partnrs , Tower Group , China Universal Asset Management Co , Belpointe Asset Management , Morgan Stanley , Jpmorgan Chase Co , Needham Company , Cytokinetics Incorporated , Archer Investment Corp , Get Free Report , Asset Management , Universal Asset Management , Investment Corp , Cytokinetics Daily , Nasdaq Cytk , Insider Trading , Nsider Trades ,

Cytokinetics, Incorporated (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,500 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) EVP Fady Ibraham Malik sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $34.86, for a total transaction of $87,150.00. Following the completion of the sale, the executive vice president now owns […] ....

United States , New Zealand General , New Zealand , Fady Ibraham Malik , Cytokinetics Incorporated , America Corp , American Century Companies Inc , Needham Company , Wellington Management Group , Norges Bank , Morgan Stanley , Vanguard Group Inc , Get Free Report , Ibraham Malik , Century Companies , Management Group , Cytokinetics Daily , Nasdaq Cytk , Insider Trading , Nsider Trades ,

Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Robert I. Blum Sells 12,500 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert I. Blum sold 12,500 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $34.90, for a total value of $436,250.00. Following the transaction, the chief executive officer now owns 441,417 shares in the company, valued […] ....

Roberti Blum , Archer Investment Corp , Affinity Asset Advisors , Cytokinetics Company Profile , Needham Company , Connor Clark Lunn Investment Management Ltd , Stonnington Group , Cantor Fitzgerald , Cytokinetics Incorporated , Get Free Report , Investment Corp , Asset Advisors , Lunn Investment Management , Cytokinetics Daily , Nasdaq Cytk , Insider Trading , Nsider Trades ,

Ironwood Investment Management LLC Sells 1,991 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)

Ironwood Investment Management LLC decreased its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 3.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,976 shares of the biopharmaceutical company’s stock after selling 1,991 shares during the quarter. […] ....

United States , Roberti Blum , Cytokinetics Incorporated , Jpmorgan Chase Co , Sectoral Asset Management Inc , Securities Exchange Commission , Morgan Stanley , Cantor Fitzgerald , Ironwood Investment Management , Financial Services Group Inc , China Universal Asset Management Co , Exchange Commission , Free Report , Investment Management , Retirement System , Financial Advisors , Universal Asset Management , Services Group , Sectoral Asset Management , Asset Management , Get Free Report , Director Wendall Wierenga , Visit Holdingschannel , Cytokinetics Daily , Nasdaq Cytk , Sec Filings ,